Novones

Novones is a global leader in biosolutions, formed in 2024 through the merger of Novozymes and Chr. Hansen. The company leverages an extensive library of microbes and enzymes to provide sustainable solutions across industries such as food and beverage, agriculture, and human health. In the healthcare sector, Novones focuses on probiotics, human milk oligosaccharides (HMOs), and enzymes that support digestive, immune, and metabolic health. Their advanced fermentation technology and large-scale manufacturing capabilities make them a primary partner for developing live biotherapeutic products. Headquartered in Denmark, Novones serves customers in over 140 countries and maintains a significant commitment to R&D and planetary health. The company operates as a key player in the transition to a bio-based global economy.